Clinical trial
PROSTACOX: Metastatic Prostate Chemotherapy
NCT00213694 · University Hospital, Rouen, Other · Completed
Key facts
| NCT number | NCT00213694 |
|---|---|
| Title | PROSTACOX : Metastatic Prostate Chemotherapy |
| Official title | Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer |
| Lead sponsor | University Hospital, Rouen, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Metastatic Prostate Cancer |
| Intervention type | Drug |
| Interventions | docetaxel and celecoxib |
| Enrollment | 52 |
| Start date | Nov 1, 2003 |
| Completion | Jun 1, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 5, 2013 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: